Authors' reply

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7064.1084a (Published 26 October 1996) Cite this as: BMJ 1996;313:1084
  1. Julia Clark, Senior registrar, paediatric infectious diseases,
  2. Andrew Cant, Consultant, paediatric immunology and infectious diseases
  1. Acute Services Newcastle General Hospital, Newcastle upon Tyne NE4 6BE

    EDITOR,—We agree with J R Greig and colleagues that, when drug resistance is suspected, more than one antituberculous drug should usually be added to treatment. This has been our practice when we have met this problem. We considered drug resistance to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription